BusinessHealth in Code’s Novel Work Published In JACC, Helps Increase Sensitivity Detection for Admera Health’s CardioGxOne™ Test Regarding Patients with High-Risk Dilated and Arrhythmogenic CardiomyopathiesBy Nasdaq OMXMay 3, 2017, 1:13 PM UTC
BusinessBiotricity Files for its Second and Final FDA 510(k) to Bring Bioflux Solution to MarketBy Nasdaq OMXApr 12, 2017, 12:00 PM UTC
BusinessRenowned Cardiologist Dr. Rony Shimony Joins Biotricity Board of AdvisorsBy Nasdaq OMXNov 1, 2016, 12:00 PM UTC
